-- AGA Medical, Citigroup, Halliburton, Ista, Quicksilver: U.S. Equity Movers
-- B y   L u   W a n g
-- 2010-10-18T14:27:12Z
-- http://www.bloomberg.com/news/2010-10-15/allergan-cablevision-systems-pioneer-natural-wd-40-u-s-equity-preview.html
Shares of the following companies
are having unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 10 a.m. in New York.  AGA Medical Holdings Inc.  (AGAM US) rallied the most in the
Russell 2000 Index, surging 41 percent to $20.69. St. Jude
Medical Inc. (STJ US) agreed  to buy the maker of medical
devices for $20.80 a share in a cash and stock transaction
valued at $1.3 billion to expand its range of heart devices.       Allergan Inc.  (AGN US) climbed 4.2 percent to $71.75 after
rising to $72.07, the highest intraday price since at least June
1989. The maker of anti-wrinkle injections said the U.S. Food
and Drug Administration approved Botox for the preventive
treatment of chronic migraines in adults, an action that may
help almost double the drug’s yearly sales to $2.3 billion.  Citigroup Inc.  (C US) gained 2.9 percent to $4.07. The
third-biggest U.S. bank reported a third-quarter profit of 7
cents a share, topping the average analyst estimate of 5 cents a
share. The firm also reported net release of reserves of $2
billion in the third quarter.  Fluor Corp.  (FLR US) fell 3.5 percent to $50.05 after
sinking 7.3 percent earlier, the most intraday since May 7. The
largest publicly traded construction and engineering company in
the U.S. lowered its full-year earnings forecast to no more than
$2.50 a share, down from its previous forecast of $2.90 a share
to $3.20 a share. The company said its third-quarter results
include a cost of about $163 million, or 90 cents a share, for
estimated cost increases on the Greater Gabbard Offshore Wind
Project.  Halliburton Co.  (HAL US) slipped the most in the Standard &
Poor’s 500 Index, falling 4 percent to $34.40, after gaining 8.5
percent in the last two weeks. The world’s second-largest
oilfield-services provider said third-quarter earnings excluding
some items were 58 cents a share, exceeding the average analyst
estimate by 3.4 percent. The beat was the smallest since the
third quarter of 2008, according to Bloomberg data.  Hasbro Inc.  (HAS US) increased 4.9 percent to $47.34 for
the biggest advance in the S&P 500. The world’s second-largest
toymaker said third-quarter earnings excluding some items were
$1.09 a share, beating the average analyst estimate in a
Bloomberg survey by 5 percent.  Ista Pharmaceuticals Inc.  (ISTA US) jumped 9.6 percent to
$4.91 after rallying to $5.17 earlier, the highest intraday
price since September 2009. The company said its Bromday eye
drop treatment won approval from the U.S. Food and Drug
Administration.  McMoRan Exploration Co.  (MMR US) fell 4.2 percent to $17.67
after erasing as much as 5.9 percent, the most intraday since
Sept. 21. The company, which has been a partner in some of the
largest U.S. offshore oil discoveries of the past decade,
reported a third-quarter net loss of 26 cents a share, worse
than the 22-cent loss forecast by analysts. Revenue fell 13.5
percent to $94.8 million, also missing analysts’ consensus
estimate of $99.7 million.  Quicksilver Resources Inc.  (KWK US) jumped 17 percent to
$14.77 for the biggest gain in the Russell 1000 Index. The
Texas-based company that develops shale gas and coal-bed methane
said it received an Oct. 15 letter from Quicksilver Energy LP
and the Darden family seeking to explore strategic alternatives.  Supertex Inc.  (SUPX US) slumped 3.9 percent to $21.56 after
falling to $21.40 earlier, the lowest intraday price since March
2009. The maker of chips for telecommunications and medical
instruments said sales in the second quarter will be no more
than $22.5 million, lower than the average analyst estimate of
$25.1 million.  Zoom Technologies Inc.  (ZOOM US) surged 14 percent to $4.66
after jumping 18 percent earlier, the most intraday since Sept.
21. The maker of electronic communication products for mobile
phones said third-quarter net income will be a range of $3.3
million to $3.5 million, topping the previous prediction of as
much as $3.3 million. Third-quarter revenue will be $68 million
to $71 million, the company said, citing success in China’s
mobile phone market.  To contact the reporter on this story:
Lu Wang in New York at   lwang8@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 